Skip to Content

Nano Mobile Healthcare Inc VNTH

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Nano Mobile Healthcare Inc engages in developing a platform technology that analyzes Volatile Organic Compound signatures in a person’s breath by using a handheld device providing immediate results. The company has identified two markets been the detection of lung cancer and the presence of marijuana in a driver’s breath. Its secondary device testing indications include forms of cancer, chronic diseases such as heart failure as well as or contagious diseases such as strep throat. Its sensor can be connected through Bluetooth to any capable smart device running an iOS or Android operating system.

Contact
3 Columbus Circle, 15th Floor
New York, NY, 10019
T +1 917 745-7202
Sector Healthcare
Industry Health Information Services
Most Recent Earnings Sep 30, 2016
Fiscal Year End Jun 30, 2017
Stock Type Distressed
Employees 18